PALI
Palisade Bio, Inc. - Common Stock (PALI)
$16
About Palisade Bio, Inc. - Common Stock (PALI)
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.
Details
Daily high
$1.22
Daily low
$1.10
Price at open
$1.22
52 Week High
$2.86
52 Week Low
$1.08
Market cap
217.8M
Dividend yield
-
Volume
477,386
Avg. volume
3.9M
P/E ratio
-2.33
Palisade Bio, Inc. - Common Stock News
Details
Daily high
$1.22
Daily low
$1.10
Price at open
$1.22
52 Week High
$2.86
52 Week Low
$1.08
Market cap
217.8M
Dividend yield
-
Volume
477,386
Avg. volume
3.9M
P/E ratio
-2.33